G71.031
Autosomal dominant limb girdle muscular dystrophy
Clinical Classification Guidelines
Inclusion Terms
- LGMD D4 calpain-3-related
- LGMD D5 collagen 6-related
- Limb girdle muscular dystrophy type 1
Medical Intelligence & Overview
Autosomal dominant limb girdle muscular dystrophy (LGMD) with the ICD-10 code G71.031 is a genetically inherited condition characterized by progressive muscle weakness, primarily affecting the muscles around the hips and shoulders. This form of muscular dystrophy is inherited in an autosomal dominant pattern, meaning only one copy of the abnormal gene is necessary to develop the disorder. It is associated with specific genetic mutations, notably the LGMD D4 calpain-3-related and LGMD D5 collagen 6-related subtypes, which influence the severity and progression of the disease. Recognized also as Limb Girdle Muscular Dystrophy type 1, this condition primarily impacts the limb girdle muscles, leading to varying degrees of disability over time.
Causes & Symptoms
Clinical Causes: Inheritance of a defective gene from at least one parent in an autosomal dominant pattern. Mutations affecting specific proteins critical for muscle structure and function, such as calpain-3 or collagen 6. Genetic variability leading to differences in disease onset and progression.
Key Symptoms: Gradual muscle weakness primarily in the hips and shoulders. Muscle wasting or atrophy in affected regions. Difficulty with movements such as walking, climbing stairs, or lifting objects. Muscle stiffness or cramps. Potential involvement of other muscles over time, including facial muscles. Possible heart or respiratory issues in more advanced stages.
Diagnostic & Treatment
Diagnosis Path: Diagnosing autosomal dominant LGMD involves a combination of clinical evaluation, family history analysis, and genetic testing. Doctors may perform muscle strength assessments, electromyography (EMG), and muscle biopsies to observe muscle tissue changes. Confirmatory genetic testing can identify mutations in genes related to calpain-3 or collagen 6, helping to determine the specific subtype and tailor management strategies accordingly.
Treatment Protocols: While there is no cure for autosomal dominant LGMD, management focuses on alleviating symptoms and maintaining quality of life. Treatment approaches may include physical therapy to improve muscle strength and flexibility, occupational therapy for daily functioning, and the use of assistive devices. Regular monitoring of cardiac and respiratory health is crucial. Medications might be prescribed to manage symptoms such as muscle cramps or weakness, and emerging therapies are under research to target underlying genetic causes.
Clinical Advice & FAQs
Billing Guidance
Is G71.031 a billable ICD-10 code?
Yes, G71.031 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G71.031?
Clinical documentation must specify the nature of Autosomal dominant limb girdle muscular dystrophy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference